Welcome to Markets Desk, your midday read on the stories moving markets and the broader world.
Dyne Therapeutics has filed a Biologics License Application with the FDA for Z-rostudirsen, its lead candidate targeting Duchenne muscular dystrophy. This is a pivotal regulatory moment for the clinical-stage company — BLA submission puts them on the clock for a formal FDA review, and investors will be watching the agency's response window closely for any priority designation signals.
Shifting to geopolitics with real market implications, Iran has begun restoring internet access following a months-long blackout, even as the United States conducts strikes on Iranian missile launch sites and peace negotiations continue in parallel. That combination of military action and diplomatic engagement creates a deeply uncertain risk backdrop, one that commodity traders in particular will be pricing carefully given the region's proximity to critical oil infrastructure.
And in the AI labor market space, the largest independent study of AI-powered hiring algorithms to date has uncovered stark racial disparities, finding that more than one in four applications from Black job seekers were routed through systems flagging federal discrimination concerns. The findings put significant legal and reputational pressure on employers relying on automated screening tools, and could accelerate regulatory scrutiny of the entire algorithmic hiring industry.
That's the tape. Markets Desk, signing off the floor.
